TI
STOK icon

Trexquant Investment’s Stoke Therapeutics STOK Stock Holding History

Trexquant Investment’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
+73,475
New +$2.36M 0.01% 1117
2025
Q2 		– Sell
-86,140
Closed -$573K – 1865
2025
Q1 		$573K Sell
86,140
-16,891
-16% -$157K 0.01% 1243
2024
Q4 		$1.14M Sell
103,031
-58,718
-36% -$721K 0.01% 1057
2024
Q3 		$1.99M Sell
161,749
-17,864
-10% -$253K 0.03% 816
2024
Q2 		$2.43M Buy
179,613
+148,637
+480% +$2.01M 0.04% 668
2024
Q1 		$418K Sell
30,976
-8,824
-22% -$53.5K 0.01% 1201
2023
Q4 		$209K Sell
39,800
-87,781
-69% -$375K ﹤0.01% 1327
2023
Q3 		$503K Buy
127,581
+79,785
+167% +$525K 0.01% 1020
2023
Q2 		$508K Sell
47,796
-77,829
-62% -$828K 0.01% 993
2023
Q1 		$1.05M Buy
125,625
+38,096
+44% +$344K 0.03% 713
2022
Q4 		$808K Buy
87,529
+37,673
+76% +$392K 0.02% 733
2022
Q3 		$640K Sell
49,856
-33,801
-40% -$539K 0.02% 707
2022
Q2 		$1.1M Buy
83,657
+67,511
+418% +$1.03M 0.05% 473
2022
Q1 		$340K Sell
16,146
-10,253
-39% -$205K 0.02% 943
2021
Q4 		$633K Buy
+26,399
New +$630K 0.04% 545
2021
Q3 		– Sell
-8,949
Closed -$301K – 1471
2021
Q2 		$301K Buy
8,949
+1,053
+13% +$37.2K 0.03% 714
2021
Q1 		$307K Buy
+7,896
New +$450K 0.03% 741

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's STOK Position: Q2 2026 in Review

Trexquant Investment opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 73,475 shares worth $2.4M. The stake represents 0.01% of the portfolio and ranks #1117 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in STOK as recently as Q1 2025.

Trexquant Investment first reported a position in STOK in Q1 2021 and has held it in 17 quarters since. The position peaked at $2.43M in Q2 2024. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Trexquant Investment held 73,475 shares of Stoke Therapeutics worth $2.4M as of Q2 2026.
  • Stoke Therapeutics was a new Trexquant Investment position in Q2 2026.
  • Stoke Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1117 holding.
  • Trexquant Investment first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • Trexquant Investment's Stoke Therapeutics position peaked at $2.43M in Q2 2024.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.